XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities    
Net income before noncontrolling interests $ 70,530 $ 58,052
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Gains attributable to the fair value of future servicing rights, net of guaranty obligation (52,730) (57,935)
Change in the fair value of premiums and origination fees 2,883 21,562
Amortization and depreciation 56,152 46,871
Provision (benefit) for credit losses (9,498) (11,320)
Gain from revaluation of previously held equity-method investment (39,641)  
Originations of loans held for sale (3,185,019) (3,577,153)
Proceeds from transfers of loans held for sale 4,198,206 4,917,187
Other operating activities, net (68,955) (81,572)
Net cash provided by (used in) operating activities 971,928 1,315,692
Cash flows from investing activities    
Capital expenditures (11,790) (1,794)
Purchase of equity-method investments (5,941) (1,124)
Purchase of pledged available-for-sale ("AFS") securities (7,010) (2,000)
Proceeds from prepayment and sale of pledged AFS securities 1,672 20,884
Investments in joint ventures (5,040) (18,445)
Distributions from joint ventures 9,241 11,419
Acquisitions, net of cash acquired (78,465) (7,506)
Originations of loans held for investment (107) (33,750)
Principal collected on loans held for investment upon payoff 53,000 113,495
Net cash provided by (used in) investing activities (44,440) 81,179
Cash flows from financing activities    
Borrowings (repayments) of warehouse notes payable, net (1,006,545) (1,400,704)
Borrowings of interim warehouse notes payable   25,313
Repayments of interim warehouse notes payable (11,200) (29,534)
Repayments of notes payable (13,759) (745)
Proceeds from issuance of common stock 153 12,606
Repurchase of common stock (27,049) (13,374)
Cash dividends paid (20,077) (16,052)
Payment of contingent consideration (17,612)  
Debt issuance costs (567) (769)
Net cash provided by (used in) financing activities (1,096,656) (1,423,259)
Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents (NOTE 2) (169,168) (26,388)
Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period 393,180 358,002
Total of cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period 224,012 331,614
Supplemental Disclosure of Cash Flow Information:    
Cash paid to third parties for interest 13,037 $ 9,621
Cash paid for income taxes $ 1,290